Table 4.

Cancer risk and prevalence as a function of FOBT and FL-DNA evaluations

iFOBT classes (ng/mL)CasesRiskFL-DNA classes (ng)CasesRiskPrevalence
iFOBT (%)iFOBT + FL-DNA (%)iFOBT + FL-DNA (%)
101-2000-98800
201010-307200
≥304100
201-1,0000-91020.91
2394.610-30924.14
≥304513.013
>1,0000-9402.52
12012.510-305211.310
≥302830.832